introduct
new
sar
ten
year
devast
epidem
sever
acut
respiratori
syndrom
sar
caus
sar
coronaviru
sarscov
result
total
death
among
confirm
case
countri
world
face
new
challeng
post
sarslik
infect
caus
anoth
novel
coronaviru
emerg
middl
east
origin
name
human
coronaviru
hcovemc
recent
renam
coronaviru
studi
group
intern
committe
taxonomi
virus
middl
east
respiratori
syndrom
coronaviru
merscov
complet
genom
viru
sequenc
releas
octob
isol
viru
two
patient
sever
communityacquir
pneumonia
bisha
kingdom
saudi
arabia
ksa
doha
qatar
first
announc
world
health
organ
septemb
may
total
number
laboratoryconfirm
case
merscov
infect
increas
death
includ
two
case
confirm
retrospect
jordanian
cluster
sever
respiratori
diseas
report
ministri
health
jordan
april
tabl
although
number
laboratoryconfirm
case
remain
limit
sever
clinic
manifest
unusu
high
mortal
rate
spread
infect
beyond
geograph
confin
middl
east
epidemiolog
evid
humantohuman
transmiss
aris
recent
cluster
case
famili
unit
kingdom
case
hospit
ksa
case
franc
case
rais
signific
concern
possibl
emerg
anoth
sarslik
epidem
near
futur
anticip
potenti
spread
highli
pathogen
viru
middl
east
europ
part
world
especi
dens
popul
southeast
asia
updat
review
latest
research
find
merscov
implic
clinic
manag
merscov
infect
essenti
viral
genom
studi
reveal
first
lineag
c
betacoronaviru
associ
human
infect
merscov
belong
genu
betacoronaviru
famili
coronavirida
order
nidoviral
coronavirus
envelop
virus
positivesens
singlestrand
rna
genom
studi
biodivers
compar
genom
phylogeni
past
year
improv
understand
famili
virus
accord
recent
classif
coronaviru
studi
group
intern
committe
taxonomi
virus
four
genera
coronavirida
name
alphacoronaviru
betacoronaviru
gammacoronaviru
deltacoronaviru
genu
alphacoronaviru
contain
two
human
coronavirus
associ
common
cold
human
coronaviru
discov
gammacoronaviru
deltacoronaviru
mainli
contain
avian
coronavirus
mammalian
coronavirus
genu
betacoronaviru
compris
four
lineag
b
c
contain
four
coronavirus
associ
human
infect
lineag
sarscov
lineag
b
merscov
lineag
c
merscov
first
known
lineag
c
betacoronaviru
associ
human
infect
phylogenet
close
relat
lineag
c
betacoronavirus
includ
tylonycteri
bat
cov
pipistrellu
bat
cov
discov
lesser
bamboo
bat
tylonycteri
pachypu
japanes
pipistrel
bat
pipistrellu
abramu
respect
captur
hong
kong
china
analysi
genom
merscov
reveal
genom
size
base
rdrp
gene
around
amino
acid
ident
molecular
clock
analysi
use
rdrp
gene
show
merscov
might
diverg
recent
common
ancestor
lineag
c
betacoronavirus
year
ad
bc
ad
postul
emerg
merscov
repres
anoth
seri
interspeci
transmiss
event
coronavirus
bat
possibl
anim
human
scenario
similar
sar
epidem
epidemiolog
report
cell
line
suscept
studi
suggest
possibl
anim
reservoir
humantohuman
transmiss
epidemiolog
linkag
anim
includ
camel
goat
sheep
farm
anim
caretak
symptom
onset
report
case
support
hypothesi
merscov
zoonot
agent
tabl
furthermor
vitro
data
cell
line
suscept
studi
show
viru
broad
speci
tropism
abl
replic
bat
primat
porcin
rabbit
civet
cell
line
case
sarscov
like
emerg
natur
anim
reservoir
horsesho
bat
rhinolophu
sp
jump
mammal
cage
wild
life
market
south
china
human
merscov
might
also
origin
bat
suscept
anim
speci
adapt
human
addit
pipistrellu
bat
natur
host
close
relat
also
found
middl
east
rousettu
rhinolophu
myoti
carollia
bat
cell
line
also
suscept
merscov
infect
vitro
activ
surveil
differ
bat
anim
speci
predominantli
found
middl
east
would
help
delin
natur
bat
reservoir
evolutionari
pathway
merscov
among
suscept
anim
speci
inde
recent
studi
show
number
differ
bat
speci
ghana
europ
infect
coronavirus
also
share
close
homolog
merscov
determin
viru
anim
host
might
turn
facilit
control
outbreak
sar
closur
wet
market
like
contribut
cessat
epidem
humantohuman
transmiss
repres
new
stage
evolut
merscov
infect
far
six
seropreval
transmiss
merscov
remain
undetermin
although
animaltohuman
humantohuman
transmiss
appear
limit
stage
fig
among
person
seek
medic
attent
hospit
jeddah
ksa
none
merscovspecif
igg
detect
indirect
immunofluoresc
assay
suggest
current
situat
like
differ
human
coronavirus
endem
human
lack
secondari
case
among
nearli
contact
case
practic
optim
infect
control
measur
diagnosi
merscov
infect
confirm
impli
novel
viru
might
less
effici
sarscov
humantohuman
transmiss
howev
find
studi
interpret
caution
two
reason
first
rel
small
number
subject
case
case
test
reliabl
laboratori
test
second
time
test
clearli
describ
might
suboptim
purpos
exclud
diagnosi
propos
second
test
perform
symptomat
patient
initi
neg
result
revers
transcriptionpolymeras
chain
reaction
rtpcr
within
first
day
symptom
onset
base
observ
sar
viral
load
peak
day
symptom
onset
therefor
appar
limit
spread
merscov
present
might
underestim
ongo
transmiss
viru
cautious
monitor
unlik
close
rel
bat
merscov
highli
pathogen
human
common
clinic
present
among
laboratoryconfirm
case
merscov
infect
acut
sever
communityacquir
pneumonia
acut
renal
failur
follow
estim
incub
period
day
tabl
unusu
among
human
infect
caus
coronavirus
sever
pneumonia
respiratori
failur
seldom
seen
except
sar
human
coronavirus
name
predominantli
caus
acut
selflimit
upper
respiratori
tract
infect
occasion
caus
lower
respiratori
tract
infect
elderli
immunocomprom
popul
two
patient
case
selflimit
mild
influenzalik
ill
requir
hospit
asymptomat
mild
infect
otherwis
detect
among
contact
confirm
case
rtpcr
upper
respiratori
tract
specimen
andor
serolog
test
saudi
resid
jeddah
indirect
immunofluoresc
antibodi
test
archiv
sera
french
hajj
pilgrim
upper
respiratori
symptom
rtpcr
prospect
collect
nasal
swab
patient
mani
underli
medic
condit
develop
rapid
clinic
deterior
lower
respiratori
tract
involv
respiratori
failur
requir
ventil
support
within
day
week
initi
system
symptom
fever
myalgia
malais
upper
respiratori
tract
symptom
rhinorrhea
sore
throat
correl
find
recent
cell
line
suscept
studi
show
merscov
replic
much
better
lower
respiratori
tract
cell
line
includ
polar
airway
epithelium
lung
adenocarcinoma
hfl
embryon
lung
fibroblast
upper
respiratori
tract
cell
line
laryng
epidermoid
carcinoma
anoth
vitro
studi
also
show
pseudostratifi
human
bronchial
epithelium
cultur
highli
permiss
merscov
infect
ex
vivo
organ
cultur
merscov
product
replic
human
bronchial
lung
tissu
wherea
sarscov
product
replic
lung
tissu
recent
macaqu
model
show
merscov
caus
acut
local
widespread
pneumonia
result
mild
moder
clinic
diseas
resembl
ill
observ
human
radiolog
pneumonia
evid
focal
consolid
involv
singl
multipl
lobe
progress
involv
bilater
lung
field
especi
lower
zone
case
thorac
comput
tomographi
scan
reveal
mediastin
hilar
lymphadenopathi
airspac
opac
air
bronchogram
scatter
groundglass
opac
interstiti
septal
thicken
nodular
upper
lobe
without
signific
pleural
pericardi
effus
acut
renal
failur
domin
clinic
featur
merscov
infect
seen
least
six
report
case
mani
remain
sever
case
probabl
also
develop
renal
impair
although
clinic
detail
avail
unusu
even
compar
sar
patient
abnorm
urinalysi
detect
viral
load
quantit
rtpcr
urin
develop
acut
renal
failur
histolog
evid
acut
tubular
necrosi
requir
renal
replac
therapi
clinic
present
correl
vitro
find
effici
replic
merscov
kidney
cell
line
includ
hek
vero
importantli
presenc
renal
involv
appear
poor
prognost
factor
renal
failur
either
die
requir
renal
replac
therapi
two
case
without
renal
impair
surviv
tabl
lack
extrapulmonari
lesion
observ
macaqu
model
merscov
infect
suggest
acut
renal
failur
like
due
hypox
damag
direct
viral
cytopath
effect
clinic
laboratori
microbiolog
find
report
merscov
infect
includ
pericard
dissemin
intravascular
coagul
leukocytosi
neutrophilia
lymphopenia
thrombocytopenia
anemia
hyponatremia
hypoalbuminemia
elev
liver
enzym
lactat
dehydrogenas
creactiv
protein
procalcitonin
level
possibl
secondari
bacteri
pneumonia
caus
klebsiella
pneumonia
staphylococcu
aureu
acinetobact
sp
coinfect
respiratori
virus
includ
influenza
type
parainfluenza
viru
interest
note
absenc
wateri
diarrhea
acut
phase
merscov
infect
despit
vitro
find
viral
replic
colon
cell
line
colorect
adenocarcinoma
contrast
sar
around
patient
develop
enterocol
remain
seen
futur
case
cohort
whether
due
underreport
genuin
differ
clinic
present
two
diseas
togeth
sever
acut
respiratori
renal
failur
clinic
featur
underscor
success
innat
immun
evas
mechan
merscov
human
lead
overwhelm
infect
possibl
cytokin
dysregul
reflect
lack
interferon
inhibit
interferon
regulatori
factor
famili
discoveri
dipeptidyl
peptidas
multifunct
typeii
transmembran
glycoprotein
exopeptidas
express
human
noncili
bronchial
renal
enter
hepat
prostat
epitheli
cell
import
regul
hormon
chemokin
bioactiv
glucos
metabol
tcell
activ
chemotaxi
modul
cell
adhes
apoptosi
regul
tumorigen
function
receptor
merscov
provid
insight
uniqu
pattern
organ
involv
unusu
sever
clinic
present
emerg
infect
clinic
util
practic
concern
publish
laboratori
diagnost
option
sever
laboratori
method
avail
establish
virolog
diagnosi
merscov
infect
definit
test
viral
cultur
respiratori
fecal
urin
tissu
specimen
andor
fourfold
rise
serum
neutral
antibodi
titer
taken
day
apart
first
clinic
isol
merscov
cultur
monkey
kidney
cell
like
vero
show
cytopath
effect
syncytium
format
round
detach
cell
subsequ
studi
identifi
variou
human
cell
type
includ
bronchial
epitheli
colon
hepat
renal
neuron
cell
monocyt
histiocyt
support
replic
merscov
howev
use
viral
cultur
limit
requir
biosafeti
level
three
set
avail
clinic
microbiolog
laboratori
serum
neutral
antibodi
test
disadvantag
requir
convalesc
sera
therefor
mainli
use
diagnosi
convalesc
instead
acut
phase
furthermor
sera
sar
patient
may
contain
lowtit
crossreact
neutral
antibodi
merscov
may
lead
wrong
serodiagnosi
especi
countri
gener
popul
previou
exposur
remain
seen
whether
neutral
antibodi
merscov
might
also
crossreact
close
relat
lineag
c
betacoronavirus
like
laboratoryconfirm
case
diagnosi
establish
detect
nucleic
acid
rtpcr
respiratori
tract
sampl
includ
combin
nose
throat
swab
sputum
tracheal
aspir
bronchoalveolar
lavag
andor
urin
taken
day
case
day
case
two
highli
sensit
realtim
rtpcr
assay
target
region
upstream
e
gene
upe
sensit
rna
copi
per
reaction
within
open
read
frame
orf
sensit
rna
copi
per
reaction
propos
screen
confirm
merscov
infect
respect
avail
half
countri
european
region
addit
test
gene
target
partial
whole
genom
sequenc
analysi
may
also
use
confirm
exampl
pancoronaviru
rtpcr
target
rdrp
gene
use
case
realtim
quantit
rtpcr
assay
target
n
gene
use
vitro
studi
may
also
use
clinic
diagnosi
although
evalu
need
potenti
diagnost
option
might
use
area
without
rtpcr
n
proteinbas
enzymelink
immunosorb
assay
shown
highli
sensit
specif
diagnosi
sar
note
detect
respiratori
virus
respiratori
tract
specimen
preclud
need
specif
merscov
test
patient
epidemiolog
risk
factor
unusu
sever
diseas
despit
antivir
treatment
exemplifi
presenc
coinfect
case
except
high
crude
mortal
rate
merscov
infect
partli
due
lack
specif
anticoronaviru
treatment
effect
vaccin
case
intens
support
treatment
extracorpor
membran
oxygen
renal
replac
therapi
empir
broadspectrum
antibacteri
antivir
agent
use
case
still
critic
condit
nearli
month
symptom
onset
also
receiv
corticosteroid
initi
phase
treatment
efficaci
unknown
use
might
limit
seriou
side
effect
avail
ecmo
organ
support
critic
phase
altern
type
interferon
appear
promis
therapeut
option
merscov
shown
much
sensit
sarscov
antivir
action
interferon
vitro
replic
merscov
shown
reduc
human
lung
ex
vivo
organ
cultur
treat
type
interferon
recent
studi
show
ribavirin
reduc
replic
merscov
vero
cell
combin
two
drug
achiev
endpoint
much
lower
concentr
might
facilit
clinic
applic
potenti
specif
antivir
target
includ
type
ii
transmembran
serin
proteas
endosom
cathepsin
respons
merscov
protein
activ
requir
viruscel
fusion
entri
viru
host
cell
identif
angiotensinconvert
enzym
aminopeptidas
n
carcinoembryon
antigenrel
cell
adhes
molecul
function
receptor
merscov
impli
vivo
manipul
level
develop
inhibitor
interfac
might
potenti
therapeut
role
merscov
infect
analogu
case
sar
final
recognit
predict
receptorbind
domain
critic
neutral
domain
residu
merscov
protein
might
facilit
vaccin
develop
emerg
infect
past
month
follow
announc
first
two
case
merscov
infect
septemb
clinician
scientist
worldwid
collabor
close
attempt
prevent
sarslik
epidem
happen
discoveri
certain
import
characterist
merscov
includ
genom
arrang
phylogenet
related
coronavirus
vitro
tissu
speci
tropism
function
receptor
enhanc
understand
clinic
present
pathogenesi
epidemiolog
design
diagnost
therapeut
option
emerg
novel
human
coronaviru
howev
key
question
concern
definit
anim
reservoir
viru
evolutionari
process
transmiss
prognost
factor
optim
treatment
modal
infect
remain
elus
importantli
increas
number
laboratoryconfirm
case
middl
east
recent
evid
humantohuman
transmiss
europ
suggest
continu
viral
adapt
human
might
preced
largescal
epidem
inde
june
accept
articl
total
number
laboratoryconfirm
case
increas
fatal
addit
cluster
case
involv
household
andor
hospit
contact
report
ksa
itali
tunisia
collabor
global
local
health
author
sustain
support
research
merscov
crucial
control
new
sar
